Stock Events

Stock Events

Search...

Adaptimmune Therapeutics (ADAP) Q4 2024 Earnings

20MarConfirmed

Q1 2024

Q2 2024

Q3 2024

Q4 2024

-0.18

-0.04

0.1

0.24

Details

Expected EPS

-0.16

Actual EPS

N/A

Surprise EPS

0.16

Surprise Percent

+100%

Description

Adaptimmune Therapeutics (ADAP) will report earnings of for Q4 2024 on March 20, 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.